Billion-dollar deal takes University of Queensland's vaccine tech to the world
The French pharma giant has agreed to acquire the biotech company holding the rights to the breakthrough.
Under the eye-watering deal, worth up to $US1.6 billion ($A2.44 billion), Sanofi will purchase Vicebio, the company licensing UQ's cutting-edge technology for commercial use.
Sanofi announced that the acquisition brings an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), both respiratory viruses currently significantly impacting global health.
'Vicebio's Molecular Clamp technology introduces a purposefully simple but thoughtful approach to further improve vaccine designs at a time when respiratory viral infections continue to impact millions globally,' Sanofi global head of vaccine research and development Jean-Francois Toussaint said.
The next-generation combination vaccine has the potential to protect older adults with a single immunisation against multiple respiratory viruses, he said.
UQ Vice-Chancellor Professor Deborah Terry described the acquisition as extraordinary validation of Australian research excellence.
'This validates 12 years of UQ research and pays tribute to our dedicated scientists who invented this patented technology,' Terry said.
The Molecular Clamp platform burst onto the global stage during the early days of COVID-19, when international health organisation CEPI called on UQ to develop a vaccine candidate using the innovative approach.
Lead researcher Professor Keith Chappell said the technology's unique design could revolutionise how quickly vaccines are developed to combat emerging viruses.
'This facilitates efficient development of multi-pathogen vaccines that will protect vulnerable populations against common viruses causing severe respiratory diseases,' Chappell explained.
The platform remains crucial for pandemic preparedness, with UQ continuing research partnerships with CEPI to stay ahead of future health threats.
European life sciences investor Medicxi-backed Vicebio holds commercial rights to the technology, while UQ maintains a stake through its commercialisation arm UniQuest.
Sanofi's deal includes an immediate $US1.15 billion payment to Vicebio shareholders, with potential milestone payments reaching $US450 million pending regulatory approvals.
The success adds to UQ's impressive track record of turning laboratory discoveries into global commercial wins.
The university boasts more than 360 US patents and has launched more than 130 start-ups from its research.
Previous UQ breakthroughs include licensing the cervical cancer vaccine Gardasil and successful sales of biotech firms Spinifex Pharmaceuticals and Inflazome.
'This deal highlights the strength of Australia's innovation ecosystem and world-class research emerging from our universities,' Terry said.
Sanofi, headquartered in Paris, has a distinguished vaccine history as the first company to supply an injectable polio vaccine and pioneer vaccines for influenza, meningitis and rabies.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Advertiser
4 hours ago
- The Advertiser
WHO urges action as mosquito-borne chikungunya spreads
The World Health Organisation has issued an urgent call for action to prevent a repeat of an epidemic of the mosquito-borne chikungunya virus that swept the globe two decades ago, as new outbreaks linked to the Indian Ocean region spread to Europe and other continents. An estimated 5.6 billion people live in areas across 119 countries at risk from the virus, which can cause high fever, joint pain and long-term disability, Diana Rojas Alvarez, a WHO medical officer, told reporters in Geneva. "We are seeing history repeating itself," she said, drawing parallels to the 2004-2005 epidemic, which affected nearly half a million people, primarily in small island territories, before spreading around the world. The current surge began in early 2025, with major outbreaks in the same Indian Ocean islands which were previously hit, including Reunion, Mayotte and Mauritius. An estimated one-third of Reunion's population has already been infected, Rojas Alvarez said. The virus is now spreading to countries such as Madagascar, Somalia and Kenya, and has shown epidemic transmission in Southeast Asia, including India. Of particular concern is the increasing number of imported cases and recent local transmission within Europe. There have been approximately 800 imported chikungunya cases in continental France since May 1, Rojas Alvarez said. Twelve local transmission episodes have been detected in several southern French regions, meaning individuals were infected by local mosquitoes without having travelled to endemic areas. A case was also detected last week in Italy. Chikungunya, for which there is no specific treatment and which is spread primarily by Aedes mosquito species, including the "tiger mosquito" which also transmits dengue, and Zika, can cause rapid and large outbreaks. As the mosquitoes bite in the daytime, prevention is key, through the use of insect repellent and long-sleeved clothing. The World Health Organisation has issued an urgent call for action to prevent a repeat of an epidemic of the mosquito-borne chikungunya virus that swept the globe two decades ago, as new outbreaks linked to the Indian Ocean region spread to Europe and other continents. An estimated 5.6 billion people live in areas across 119 countries at risk from the virus, which can cause high fever, joint pain and long-term disability, Diana Rojas Alvarez, a WHO medical officer, told reporters in Geneva. "We are seeing history repeating itself," she said, drawing parallels to the 2004-2005 epidemic, which affected nearly half a million people, primarily in small island territories, before spreading around the world. The current surge began in early 2025, with major outbreaks in the same Indian Ocean islands which were previously hit, including Reunion, Mayotte and Mauritius. An estimated one-third of Reunion's population has already been infected, Rojas Alvarez said. The virus is now spreading to countries such as Madagascar, Somalia and Kenya, and has shown epidemic transmission in Southeast Asia, including India. Of particular concern is the increasing number of imported cases and recent local transmission within Europe. There have been approximately 800 imported chikungunya cases in continental France since May 1, Rojas Alvarez said. Twelve local transmission episodes have been detected in several southern French regions, meaning individuals were infected by local mosquitoes without having travelled to endemic areas. A case was also detected last week in Italy. Chikungunya, for which there is no specific treatment and which is spread primarily by Aedes mosquito species, including the "tiger mosquito" which also transmits dengue, and Zika, can cause rapid and large outbreaks. As the mosquitoes bite in the daytime, prevention is key, through the use of insect repellent and long-sleeved clothing. The World Health Organisation has issued an urgent call for action to prevent a repeat of an epidemic of the mosquito-borne chikungunya virus that swept the globe two decades ago, as new outbreaks linked to the Indian Ocean region spread to Europe and other continents. An estimated 5.6 billion people live in areas across 119 countries at risk from the virus, which can cause high fever, joint pain and long-term disability, Diana Rojas Alvarez, a WHO medical officer, told reporters in Geneva. "We are seeing history repeating itself," she said, drawing parallels to the 2004-2005 epidemic, which affected nearly half a million people, primarily in small island territories, before spreading around the world. The current surge began in early 2025, with major outbreaks in the same Indian Ocean islands which were previously hit, including Reunion, Mayotte and Mauritius. An estimated one-third of Reunion's population has already been infected, Rojas Alvarez said. The virus is now spreading to countries such as Madagascar, Somalia and Kenya, and has shown epidemic transmission in Southeast Asia, including India. Of particular concern is the increasing number of imported cases and recent local transmission within Europe. There have been approximately 800 imported chikungunya cases in continental France since May 1, Rojas Alvarez said. Twelve local transmission episodes have been detected in several southern French regions, meaning individuals were infected by local mosquitoes without having travelled to endemic areas. A case was also detected last week in Italy. Chikungunya, for which there is no specific treatment and which is spread primarily by Aedes mosquito species, including the "tiger mosquito" which also transmits dengue, and Zika, can cause rapid and large outbreaks. As the mosquitoes bite in the daytime, prevention is key, through the use of insect repellent and long-sleeved clothing. The World Health Organisation has issued an urgent call for action to prevent a repeat of an epidemic of the mosquito-borne chikungunya virus that swept the globe two decades ago, as new outbreaks linked to the Indian Ocean region spread to Europe and other continents. An estimated 5.6 billion people live in areas across 119 countries at risk from the virus, which can cause high fever, joint pain and long-term disability, Diana Rojas Alvarez, a WHO medical officer, told reporters in Geneva. "We are seeing history repeating itself," she said, drawing parallels to the 2004-2005 epidemic, which affected nearly half a million people, primarily in small island territories, before spreading around the world. The current surge began in early 2025, with major outbreaks in the same Indian Ocean islands which were previously hit, including Reunion, Mayotte and Mauritius. An estimated one-third of Reunion's population has already been infected, Rojas Alvarez said. The virus is now spreading to countries such as Madagascar, Somalia and Kenya, and has shown epidemic transmission in Southeast Asia, including India. Of particular concern is the increasing number of imported cases and recent local transmission within Europe. There have been approximately 800 imported chikungunya cases in continental France since May 1, Rojas Alvarez said. Twelve local transmission episodes have been detected in several southern French regions, meaning individuals were infected by local mosquitoes without having travelled to endemic areas. A case was also detected last week in Italy. Chikungunya, for which there is no specific treatment and which is spread primarily by Aedes mosquito species, including the "tiger mosquito" which also transmits dengue, and Zika, can cause rapid and large outbreaks. As the mosquitoes bite in the daytime, prevention is key, through the use of insect repellent and long-sleeved clothing.
West Australian
7 hours ago
- West Australian
WHO urges action as mosquito-borne chikungunya spreads
The World Health Organisation has issued an urgent call for action to prevent a repeat of an epidemic of the mosquito-borne chikungunya virus that swept the globe two decades ago, as new outbreaks linked to the Indian Ocean region spread to Europe and other continents. An estimated 5.6 billion people live in areas across 119 countries at risk from the virus, which can cause high fever, joint pain and long-term disability, Diana Rojas Alvarez, a WHO medical officer, told reporters in Geneva. "We are seeing history repeating itself," she said, drawing parallels to the 2004-2005 epidemic, which affected nearly half a million people, primarily in small island territories, before spreading around the world. The current surge began in early 2025, with major outbreaks in the same Indian Ocean islands which were previously hit, including Reunion, Mayotte and Mauritius. An estimated one-third of Reunion's population has already been infected, Rojas Alvarez said. The virus is now spreading to countries such as Madagascar, Somalia and Kenya, and has shown epidemic transmission in Southeast Asia, including India. Of particular concern is the increasing number of imported cases and recent local transmission within Europe. There have been approximately 800 imported chikungunya cases in continental France since May 1, Rojas Alvarez said. Twelve local transmission episodes have been detected in several southern French regions, meaning individuals were infected by local mosquitoes without having travelled to endemic areas. A case was also detected last week in Italy. Chikungunya, for which there is no specific treatment and which is spread primarily by Aedes mosquito species, including the "tiger mosquito" which also transmits dengue, and Zika, can cause rapid and large outbreaks. As the mosquitoes bite in the daytime, prevention is key, through the use of insect repellent and long-sleeved clothing.
Perth Now
7 hours ago
- Perth Now
WHO urges action as mosquito-borne chikungunya spreads
The World Health Organisation has issued an urgent call for action to prevent a repeat of an epidemic of the mosquito-borne chikungunya virus that swept the globe two decades ago, as new outbreaks linked to the Indian Ocean region spread to Europe and other continents. An estimated 5.6 billion people live in areas across 119 countries at risk from the virus, which can cause high fever, joint pain and long-term disability, Diana Rojas Alvarez, a WHO medical officer, told reporters in Geneva. "We are seeing history repeating itself," she said, drawing parallels to the 2004-2005 epidemic, which affected nearly half a million people, primarily in small island territories, before spreading around the world. The current surge began in early 2025, with major outbreaks in the same Indian Ocean islands which were previously hit, including Reunion, Mayotte and Mauritius. An estimated one-third of Reunion's population has already been infected, Rojas Alvarez said. The virus is now spreading to countries such as Madagascar, Somalia and Kenya, and has shown epidemic transmission in Southeast Asia, including India. Of particular concern is the increasing number of imported cases and recent local transmission within Europe. There have been approximately 800 imported chikungunya cases in continental France since May 1, Rojas Alvarez said. Twelve local transmission episodes have been detected in several southern French regions, meaning individuals were infected by local mosquitoes without having travelled to endemic areas. A case was also detected last week in Italy. Chikungunya, for which there is no specific treatment and which is spread primarily by Aedes mosquito species, including the "tiger mosquito" which also transmits dengue, and Zika, can cause rapid and large outbreaks. As the mosquitoes bite in the daytime, prevention is key, through the use of insect repellent and long-sleeved clothing.
